ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meningococcal Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-11140
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Meningococcal Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Meningococcal Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-11140
Report
May 2025
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
GSK
Merck
CSL Limited
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
Hualan Bio
Walvax
Zhifei
China
China National Biotec Group

Meningococcal Vaccine Market Size

In 2024, the global market size of Meningococcal Vaccine was estimated to be worth US$ 285 million and is forecast to reach approximately US$ 384 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.

Meningococcal Vaccine Market

Meningococcal Vaccine Market

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.
In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meningococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Vaccine.
The Meningococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (10K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meningococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Meningococcal Vaccine Market Report

Report Metric Details
Report Name Meningococcal Vaccine Market
Forecasted market size in 2031 approximately US$ 384 million
CAGR 4.4%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • 6 Months-15Year
  • over 3 Year
  • over 2 Year
  • over 3 Months
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Meningococcal Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Meningococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Meningococcal Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Meningococcal Vaccine Market size in 2031?

Ans: The Meningococcal Vaccine Market size in 2031 will be approximately US$ 384 million.

What is the market share of major companies in Meningococcal Vaccine Market?

Ans: Global top five players hold a share about 80%.

What is the Meningococcal Vaccine Market share by type?

Ans: In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%.

Who are the main players in the Meningococcal Vaccine Market report?

Ans: The main players in the Meningococcal Vaccine Market are Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei

What are the Application segmentation covered in the Meningococcal Vaccine Market report?

Ans: The Applications covered in the Meningococcal Vaccine Market report are 6 Months-15Year, over 3 Year, over 2 Year, over 3 Months

What are the Type segmentation covered in the Meningococcal Vaccine Market report?

Ans: The Types covered in the Meningococcal Vaccine Market report are Meningtits A, Polysaccharide Meningtitis AC, Meningitis ACYW

Recommended Reports

Human & Pediatric Vaccines

Meningococcal & Meningitis

Respiratory & Influenza Vaccines

Market trends :

Topic Trends
Global the global meningococcal vaccine market is experiencing steady growth driven by increased immunization initiatives and high efficacy rates, with polysaccharide meningitis AC vaccines dominating due to broad application in pediatric and adolescent populations.
Type Polysaccharide Meningtitis AC - polysaccharide meningitis AC vaccines continue to lead the market, accounting for the majority of sales due to widespread use in routine immunization programs.
Application 6 Months-15Year - vaccination programs targeting the 6 months to 15 years age group remain the primary driver of demand for meningococcal vaccines globally.
Region Europe - europe maintains the largest regional share in the meningococcal vaccine market, supported by robust public health policies and high vaccination coverage.
1 Study Coverage
1.1 Meningococcal Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Meningtits A
1.2.3 Polysaccharide Meningtitis AC
1.2.4 Meningitis ACYW
1.3 Market by Application
1.3.1 Global Meningococcal Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 6 Months-15Year
1.3.3 over 3 Year
1.3.4 over 2 Year
1.3.5 over 3 Months
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Meningococcal Vaccine Market Size Estimates and Forecasts
2.1.1 Global Meningococcal Vaccine Revenue 2020-2031
2.1.2 Global Meningococcal Vaccine Sales 2020-2031
2.2 Meningococcal Vaccine Market Size by Region: 2024 Versus 2031
2.3 Meningococcal Vaccine Sales by Region (2020-2031)
2.3.1 Global Meningococcal Vaccine Sales by Region: 2020-2025
2.3.2 Global Meningococcal Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Meningococcal Vaccine Sales Market Share by Region (2020-2031)
2.4 Meningococcal Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Meningococcal Vaccine Revenue by Region: 2020-2025
2.4.2 Global Meningococcal Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Meningococcal Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Meningococcal Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Meningococcal Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Meningococcal Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Meningococcal Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Meningococcal Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Meningococcal Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Meningococcal Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Meningococcal Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Meningococcal Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Meningococcal Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Meningococcal Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Meningococcal Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Meningococcal Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Meningococcal Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Meningtits A of Meningococcal Vaccine Revenue Market Share by Application
3.3.2 Polysaccharide Meningtitis AC of Meningococcal Vaccine Revenue Market Share by Application
3.3.3 Meningitis ACYW of Meningococcal Vaccine Revenue Market Share by Application
4 Global Meningococcal Vaccine by Manufacturers
4.1 Global Top Meningococcal Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Meningococcal Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Meningococcal Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Meningococcal Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Meningococcal Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Meningococcal Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Meningococcal Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Meningococcal Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Meningococcal Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Meningococcal Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Meningococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Meningococcal Vaccine Market
4.5.3 Manufacturers Meningococcal Vaccine Product Type and Application
4.5.4 Meningtits A Market Sales of Meningococcal Vaccine by Manufacturer
4.5.5 Polysaccharide Meningtitis AC Market Sales of Meningococcal Vaccine by Manufacturer
4.5.6 Meningitis ACYW Market Sales of Meningococcal Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Novartis
5.1.1 Novartis Company Information
5.1.2 Novartis Description, Business Overview
5.1.3 Novartis Meningococcal Vaccine Products Offered
5.1.4 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Novartis Meningococcal Vaccine Sales by Product in 2024
5.1.6 Novartis Meningococcal Vaccine Sales by Application in 2024
5.1.7 Novartis Meningococcal Vaccine Sales by Geographic Area in 2024
5.1.8 Novartis Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK Meningococcal Vaccine Products Offered
5.2.4 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK Meningococcal Vaccine Sales by Product in 2024
5.2.6 GSK Meningococcal Vaccine Sales by Application in 2024
5.2.7 GSK Meningococcal Vaccine Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Merck
5.3.1 Merck Company Information
5.3.2 Merck Description, Business Overview
5.3.3 Merck Meningococcal Vaccine Products Offered
5.3.4 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Merck Meningococcal Vaccine Sales by Product in 2024
5.3.6 Merck Meningococcal Vaccine Sales by Application in 2024
5.3.7 Merck Meningococcal Vaccine Sales by Geographic Area in 2024
5.3.8 Merck Recent Developments
5.4 CSL
5.4.1 CSL Company Information
5.4.2 CSL Description, Business Overview
5.4.3 CSL Meningococcal Vaccine Products Offered
5.4.4 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 CSL Meningococcal Vaccine Sales by Product in 2024
5.4.6 CSL Meningococcal Vaccine Sales by Application in 2024
5.4.7 CSL Meningococcal Vaccine Sales by Geographic Area in 2024
5.4.8 CSL Recent Developments
5.5 Baxter
5.5.1 Baxter Company Information
5.5.2 Baxter Description, Business Overview
5.5.3 Baxter Meningococcal Vaccine Products Offered
5.5.4 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Baxter Meningococcal Vaccine Sales by Product in 2024
5.5.6 Baxter Meningococcal Vaccine Sales by Application in 2024
5.5.7 Baxter Meningococcal Vaccine Sales by Geographic Area in 2024
5.5.8 Baxter Recent Developments
5.6 JN International Medical Corporation
5.6.1 JN International Medical Corporation Company Information
5.6.2 JN International Medical Corporation Description, Business Overview
5.6.3 JN International Medical Corporation Meningococcal Vaccine Products Offered
5.6.4 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 JN International Medical Corporation Meningococcal Vaccine Sales by Product in 2024
5.6.6 JN International Medical Corporation Meningococcal Vaccine Sales by Application in 2024
5.6.7 JN International Medical Corporation Meningococcal Vaccine Sales by Geographic Area in 2024
5.6.8 JN International Medical Corporation Recent Developments
5.7 Serum Institute of India
5.7.1 Serum Institute of India Company Information
5.7.2 Serum Institute of India Description, Business Overview
5.7.3 Serum Institute of India Meningococcal Vaccine Products Offered
5.7.4 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Serum Institute of India Meningococcal Vaccine Sales by Product in 2024
5.7.6 Serum Institute of India Meningococcal Vaccine Sales by Application in 2024
5.7.7 Serum Institute of India Meningococcal Vaccine Sales by Geographic Area in 2024
5.7.8 Serum Institute of India Recent Developments
5.8 Bio-Med
5.8.1 Bio-Med Company Information
5.8.2 Bio-Med Description, Business Overview
5.8.3 Bio-Med Meningococcal Vaccine Products Offered
5.8.4 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Bio-Med Meningococcal Vaccine Sales by Product in 2024
5.8.6 Bio-Med Meningococcal Vaccine Sales by Application in 2024
5.8.7 Bio-Med Meningococcal Vaccine Sales by Geographic Area in 2024
5.8.8 Bio-Med Recent Developments
5.9 China National Biotec Group
5.9.1 China National Biotec Group Company Information
5.9.2 China National Biotec Group Description, Business Overview
5.9.3 China National Biotec Group Meningococcal Vaccine Products Offered
5.9.4 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 China National Biotec Group Meningococcal Vaccine Sales by Product in 2024
5.9.6 China National Biotec Group Meningococcal Vaccine Sales by Application in 2024
5.9.7 China National Biotec Group Meningococcal Vaccine Sales by Geographic Area in 2024
5.9.8 China National Biotec Group Recent Developments
5.10 Hualan Bio
5.10.1 Hualan Bio Company Information
5.10.2 Hualan Bio Description, Business Overview
5.10.3 Hualan Bio Meningococcal Vaccine Products Offered
5.10.4 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Hualan Bio Meningococcal Vaccine Sales by Product in 2024
5.10.6 Hualan Bio Meningococcal Vaccine Sales by Application in 2024
5.10.7 Hualan Bio Meningococcal Vaccine Sales by Geographic Area in 2024
5.10.8 Hualan Bio Recent Developments
5.11 Walvax
5.11.1 Walvax Company Information
5.11.2 Walvax Description, Business Overview
5.11.3 Walvax Meningococcal Vaccine Products Offered
5.11.4 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Walvax Meningococcal Vaccine Sales by Product in 2024
5.11.6 Walvax Meningococcal Vaccine Sales by Application in 2024
5.11.7 Walvax Meningococcal Vaccine Sales by Geographic Area in 2024
5.11.8 Walvax Recent Developments
5.12 Zhifei
5.12.1 Zhifei Company Information
5.12.2 Zhifei Description, Business Overview
5.12.3 Zhifei Meningococcal Vaccine Products Offered
5.12.4 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Zhifei Meningococcal Vaccine Sales by Product in 2024
5.12.6 Zhifei Meningococcal Vaccine Sales by Application in 2024
5.12.7 Zhifei Meningococcal Vaccine Sales by Geographic Area in 2024
5.12.8 Zhifei Recent Developments
6 North America
6.1 North America Meningococcal Vaccine Market Size YoY Growth 2020-2031
6.2 North America Meningococcal Vaccine Market Facts & Figures by Country
6.2.1 North America Meningococcal Vaccine Sales by Country (2020-2031)
6.2.2 North America Meningococcal Vaccine Revenue by Country (2020-2031)
6.3 North America Meningococcal Vaccine Sales by Type (2020-2025)
6.4 North America Meningococcal Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Meningococcal Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Meningococcal Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Meningococcal Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Meningococcal Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Meningococcal Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Meningococcal Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Meningococcal Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Meningococcal Vaccine Market Facts & Figures by Country
8.2.1 Europe Meningococcal Vaccine Sales by Country (2020-2031)
8.2.2 Europe Meningococcal Vaccine Revenue by Country (2020-2031)
8.3 Europe Meningococcal Vaccine Sales by Type (2020-2025)
8.4 Europe Meningococcal Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Meningococcal Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Meningococcal Vaccine Market Facts & Figures by Country
9.2.1 Latin America Meningococcal Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Meningococcal Vaccine Revenue by Country (2020-2031)
9.3 Latin America Meningococcal Vaccine Sales by Type (2020-2025)
9.4 Latin America Meningococcal Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Meningococcal Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Meningococcal Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Meningococcal Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Meningococcal Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Meningococcal Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Meningococcal Vaccine Supply Chain Analysis
11.2 Meningococcal Vaccine Key Raw Materials and Upstream Suppliers
11.3 Meningococcal Vaccine Clients Analysis
11.4 Meningococcal Vaccine Sales Channel and Sales Model Analysis
11.4.1 Meningococcal Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Meningococcal Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Meningococcal Vaccine Distributors
12 Meningococcal Vaccine Market Dynamics
12.1 Meningococcal Vaccine Industry Trends
12.2 Meningococcal Vaccine Market Drivers
12.3 Meningococcal Vaccine Market Challenges
12.4 Meningococcal Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Novartis
GSK
Merck
CSL Limited
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
Hualan Bio
Walvax
Zhifei
China
China National Biotec Group
List of Tables
 Table 1. Global Meningococcal Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Meningococcal Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Meningococcal Vaccine Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Meningococcal Vaccine Sales by Region (2020-2025) & (10K Pcs)
 Table 5. Global Meningococcal Vaccine Sales Forecast by Region (2026-2031) & (10K Pcs)
 Table 6. Global Meningococcal Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Meningococcal Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Meningococcal Vaccine Sales Volume by Type (2020-2025) & (10K Pcs)
 Table 9. Global Meningococcal Vaccine Sales Volume by Type (2026-2031) & (10K Pcs)
 Table 10. Global Meningococcal Vaccine Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Meningococcal Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Meningococcal Vaccine Sales Volume by Application (2020-2025) & (10K Pcs)
 Table 13. Global Meningococcal Vaccine Sales Volume by Application (2026-2031) & (10K Pcs)
 Table 14. Global Meningococcal Vaccine Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Meningococcal Vaccine Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Meningococcal Vaccine Sales by Manufacturer (2020-2025) & (10K Pcs)
 Table 17. Global Meningococcal Vaccine Sales Share by Manufacturer (2020-2025)
 Table 18. Meningococcal Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Meningococcal Vaccine Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Meningococcal Vaccine Price (2020-2025) & (USD/Pcs)
 Table 21. Ranking of Global Top Meningococcal Vaccine Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2024)
 Table 24. Meningococcal Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Meningococcal Vaccine Market
 Table 26. Manufacturers Meningococcal Vaccine Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Novartis Company Information
 Table 29. Novartis Description and Business Overview
 Table 30. Novartis Meningococcal Vaccine Product
 Table 31. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 32. Novartis Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 33. Novartis Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 34. Novartis Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 35. Novartis Recent Developments
 Table 36. GSK Company Information
 Table 37. GSK Description and Business Overview
 Table 38. GSK Meningococcal Vaccine Product
 Table 39. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 40. GSK Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 41. GSK Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 42. GSK Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 43. GSK Recent Developments
 Table 44. Merck Company Information
 Table 45. Merck Description and Business Overview
 Table 46. Merck Meningococcal Vaccine Product
 Table 47. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 48. Merck Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 49. Merck Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 50. Merck Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 51. Merck Recent Developments
 Table 52. CSL Company Information
 Table 53. CSL Description and Business Overview
 Table 54. CSL Meningococcal Vaccine Product
 Table 55. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 56. CSL Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 57. CSL Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 58. CSL Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 59. CSL Recent Developments
 Table 60. Baxter Company Information
 Table 61. Baxter Description and Business Overview
 Table 62. Baxter Meningococcal Vaccine Product
 Table 63. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 64. Baxter Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 65. Baxter Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 66. Baxter Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 67. Baxter Recent Developments
 Table 68. JN International Medical Corporation Company Information
 Table 69. JN International Medical Corporation Description and Business Overview
 Table 70. JN International Medical Corporation Meningococcal Vaccine Product
 Table 71. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 72. JN International Medical Corporation Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 73. JN International Medical Corporation Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 74. JN International Medical Corporation Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 75. JN International Medical Corporation Recent Developments
 Table 76. Serum Institute of India Company Information
 Table 77. Serum Institute of India Description and Business Overview
 Table 78. Serum Institute of India Meningococcal Vaccine Product
 Table 79. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 80. Serum Institute of India Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 81. Serum Institute of India Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 82. Serum Institute of India Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 83. Serum Institute of India Recent Developments
 Table 84. Bio-Med Company Information
 Table 85. Bio-Med Description and Business Overview
 Table 86. Bio-Med Meningococcal Vaccine Product
 Table 87. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Bio-Med Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 89. Bio-Med Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 90. Bio-Med Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 91. Bio-Med Recent Developments
 Table 92. China National Biotec Group Company Information
 Table 93. China National Biotec Group Description and Business Overview
 Table 94. China National Biotec Group Meningococcal Vaccine Product
 Table 95. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 96. China National Biotec Group Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 97. China National Biotec Group Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 98. China National Biotec Group Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 99. China National Biotec Group Recent Developments
 Table 100. Hualan Bio Company Information
 Table 101. Hualan Bio Description and Business Overview
 Table 102. Hualan Bio Meningococcal Vaccine Product
 Table 103. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 104. Hualan Bio Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 105. Hualan Bio Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 106. Hualan Bio Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 107. Hualan Bio Recent Developments
 Table 108. Walvax Company Information
 Table 109. Walvax Description and Business Overview
 Table 110. Walvax Meningococcal Vaccine Product
 Table 111. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 112. Walvax Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 113. Walvax Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 114. Walvax Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 115. Walvax Recent Developments
 Table 116. Zhifei Company Information
 Table 117. Zhifei Description and Business Overview
 Table 118. Zhifei Meningococcal Vaccine Product
 Table 119. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 120. Zhifei Sales Proportion of Meningococcal Vaccine by Product in 2024
 Table 121. Zhifei Sales Proportion of Meningococcal Vaccine by Application in 2024
 Table 122. Zhifei Sales Proportion of Meningococcal Vaccine by Geographic Area in 2024
 Table 123. Zhifei Recent Developments
 Table 124. North America Meningococcal Vaccine Sales by Country (2020-2025) & (10K Pcs)
 Table 125. North America Meningococcal Vaccine Sales by Country (2026-2031) & (10K Pcs)
 Table 126. North America Meningococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 127. North America Meningococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 128. North America Meningococcal Vaccine Sales by Type (2020-2025) & (10K Pcs)
 Table 129. North America Meningococcal Vaccine Sales by Application (2020-2025) & (10K Pcs)
 Table 130. Asia-Pacific Meningococcal Vaccine Sales by Region (2020-2025) & (10K Pcs)
 Table 131. Asia-Pacific Meningococcal Vaccine Sales by Region (2026-2031) & (10K Pcs)
 Table 132. Asia-Pacific Meningococcal Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 133. Asia-Pacific Meningococcal Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 134. Asia-Pacific Meningococcal Vaccine Sales by Type (2020-2025) & (10K Pcs)
 Table 135. Asia-Pacific Meningococcal Vaccine Sales by Application (2020-2025) & (10K Pcs)
 Table 136. Europe Meningococcal Vaccine Sales by Country (2020-2025) & (10K Pcs)
 Table 137. Europe Meningococcal Vaccine Sales by Country (2026-2031) & (10K Pcs)
 Table 138. Europe Meningococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 139. Europe Meningococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 140. Europe Meningococcal Vaccine Sales by Type (2020-2025) & (10K Pcs)
 Table 141. Europe Meningococcal Vaccine Sales by Application (2020-2025) & (10K Pcs)
 Table 142. Latin America Meningococcal Vaccine Sales by Country (2020-2025) & (10K Pcs)
 Table 143. Latin America Meningococcal Vaccine Sales by Country (2026-2031) & (10K Pcs)
 Table 144. Latin America Meningococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 145. Latin America Meningococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 146. Latin America Meningococcal Vaccine Sales by Type (2020-2025) & (10K Pcs)
 Table 147. Latin America Meningococcal Vaccine Sales by Application (2020-2025) & (10K Pcs)
 Table 148. Middle East and Africa Meningococcal Vaccine Sales by Country (2020-2025) & (10K Pcs)
 Table 149. Middle East and Africa Meningococcal Vaccine Sales by Country (2026-2031) & (10K Pcs)
 Table 150. Middle East and Africa Meningococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 151. Middle East and Africa Meningococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 152. Middle East and Africa Meningococcal Vaccine Sales by Type (2020-2025) & (10K Pcs)
 Table 153. Middle East and Africa Meningococcal Vaccine Sales by Application (2020-2025) & (10K Pcs)
 Table 154. Meningococcal Vaccine Key Raw Materials, Industry Status and Trend
 Table 155. Meningococcal Vaccine Key Raw Materials and Upstream Suppliers
 Table 156. Meningococcal Vaccine Clients Status and Trend
 Table 157. Meningococcal Vaccine Typical Clients
 Table 158. Meningococcal Vaccine Distributors
 Table 159. Meningococcal Vaccine Market Trends
 Table 160. Meningococcal Vaccine Market Drivers
 Table 161. Meningococcal Vaccine Market Challenges
 Table 162. Meningococcal Vaccine Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Meningococcal Vaccine Product Picture
 Figure 2. Global Meningococcal Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Meningococcal Vaccine Sales Market Share by Type in 2024 & 2031
 Figure 4. Meningtits A Product Picture
 Figure 5. Polysaccharide Meningtitis AC Product Picture
 Figure 6. Meningitis ACYW Product Picture
 Figure 7. Global Meningococcal Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Meningococcal Vaccine Sales Market Share by Application in 2024 & 2031
 Figure 9. 6 Months-15Year
 Figure 10. over 3 Year
 Figure 11. over 2 Year
 Figure 12. over 3 Months
 Figure 13. Meningococcal Vaccine Report Years Considered
 Figure 14. Global Meningococcal Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Meningococcal Vaccine Market Size 2020-2031 (US$ Million)
 Figure 16. Global Meningococcal Vaccine Sales 2020-2031 (10K Pcs)
 Figure 17. Global Meningococcal Vaccine Sales Market Share Forecast by Region (2020-2031)
 Figure 18. Global Meningococcal Vaccine Revenue Market Share by Region (2020-2031)
 Figure 19. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2020-2031)
 Figure 20. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2020-2031)
 Figure 21. Meningococcal Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Pcs)
 Figure 22. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2020-2031)
 Figure 23. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Meningococcal Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Pcs)
 Figure 25. Meningtits A of Meningococcal Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Polysaccharide Meningtitis AC of Meningococcal Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Meningitis ACYW of Meningococcal Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Global Meningococcal Vaccine Sales Share by Manufacturer in 2024
 Figure 29. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 30. Meningtits A Market Sales Proportion by Manufacturer in 2024
 Figure 31. Polysaccharide Meningtitis AC Market Sales Proportion by Manufacturer in 2024
 Figure 32. Meningitis ACYW Market Sales Proportion by Manufacturer in 2024
 Figure 33. North America Meningococcal Vaccine Revenue 2020-2031 (US$ Million)
 Figure 34. North America Meningococcal Vaccine Sales Market Share by Type (2020-2025)
 Figure 35. North America Meningococcal Vaccine Sales Market Share by Application (2020-2025)
 Figure 36. Asia-Pacific Meningococcal Vaccine Revenue 2020-2031 (US$ Million)
 Figure 37. Asia-Pacific Meningococcal Vaccine Sales Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Meningococcal Vaccine Revenue Market Share by Region (2020-2031)
 Figure 39. Asia-Pacific Meningococcal Vaccine Sales Market Share by Type (2020-2025)
 Figure 40. Asia-Pacific Meningococcal Vaccine Sales Market Share by Application (2020-2025)
 Figure 41. Europe Meningococcal Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Europe Meningococcal Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Europe Meningococcal Vaccine Revenue Market Share by Country (2020-2031)
 Figure 44. Europe Meningococcal Vaccine Sales Market Share by Type (2020-2025)
 Figure 45. Europe Meningococcal Vaccine Sales Market Share by Application (2020-2025)
 Figure 46. Latin America Meningococcal Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Latin America Meningococcal Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Meningococcal Vaccine Revenue Market Share by Country (2020-2025)
 Figure 49. Latin America Meningococcal Vaccine Sales Market Share by Type (2020-2025)
 Figure 50. Latin America Meningococcal Vaccine Sales Market Share by Application (2020-2025)
 Figure 51. Middle East and Africa Meningococcal Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 52. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Meningococcal Vaccine Sales Market Share by Type (2020-2025)
 Figure 55. Middle East and Africa Meningococcal Vaccine Sales Market Share by Application (2020-2025)
 Figure 56. Meningococcal Vaccine Supply Chain (Upstream and Downstream Market)
 Figure 57. Global Production Market Share of Meningococcal Vaccine Raw Materials by Region in 2024
 Figure 58. Meningococcal Vaccine Distribution Channels
 Figure 59. Global Meningococcal Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 60. Global Meningococcal Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Meningococcal Infections Vaccine Market Insights Forecast to 2030
Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningococcal Infections Treatment Market Research Report 2024
Meningococcal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningococcal Polysaccharide Vaccine Market Research Report 2025
Vaccine for Non infectious Meningitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2024
Meningococcal Group B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prevent Meningitis Vaccine Market Research Report 2025
Meningitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningococcal Meningitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Research Report 2025
Global Meningococcal Group A and C Conjugate Vaccine Market Research Report 2024
Global Meningitis Vaccine Market Research Report 2025
Global Neisseria meningitidis Infections Drug Market Research Report 2024
Global Vaccines For Children Market Insights Forecast to 2030
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Pneumococcal Vaccination Market Research Report 2025
Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningitis Medication Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions